These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1631808)
21. Clinical use of thrombolytic agents in venous thromboembolism. Sasahara AA; Sharma GV; Tow DE; McIntyre KM; Parisi AF; Cella G Arch Intern Med; 1982 Apr; 142(4):684-8. PubMed ID: 7073411 [TBL] [Abstract][Full Text] [Related]
22. Plasma fibrinolysis and postoperative deep vein thrombosis. Macintyre IM; Webber RG; Crispin JR; Jones DR; Wood JK; Allan NC; Prescott RJ; Ruckley CV Br J Surg; 1976 Sep; 63(9):694-7. PubMed ID: 963414 [TBL] [Abstract][Full Text] [Related]
23. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase. Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163 [TBL] [Abstract][Full Text] [Related]
24. Treatment of pulmonary embolism and deep vein thrombosis with thrombolytic therapy. Volgesang GB; Bell WR Clin Chest Med; 1984 Sep; 5(3):487-94. PubMed ID: 6386293 [TBL] [Abstract][Full Text] [Related]
26. [Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters]. Marchena Yglesias PJ; Nieto Rodríguez JA; Serrano Martínez S; Belinchón Moya O; Cortés Carmona A; Díaz de Tuesta A; Bruscas Alijarde MJ; Ruiz Ribó MD An Med Interna; 2006 Mar; 23(3):105-10. PubMed ID: 16737429 [TBL] [Abstract][Full Text] [Related]
27. [Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of pulmonary embolism]. Mühl D Orv Hetil; 2008 May; 149(20):935-48. PubMed ID: 18467263 [TBL] [Abstract][Full Text] [Related]